BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer

Name: BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
License: Public Domain

Jonsson Comprehensive Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

advanced hepatocellular carcinoma, bclc stage b hepatocellular carcinoma, bclc stage c hepatocellular carcinoma, refractory hepatocellular carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325301
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.